help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C.
Right arrow Articles by Dong, J.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C.
Right arrow Articles by Dong, J.-T.
(American Journal of Pathology. 2003;162:1349-1354.)
© 2003 American Society for Investigative Pathology

Deletion, Mutation, and Loss of Expression of KLF6 in Human Prostate Cancer

Ceshi Chen*, Eija-Riitta Hyytinen{dagger}, Xiaodong Sun*, Heikki J. Helin{ddagger}, Pasi A. Koivisto{dagger}, Henry F. Frierson, Jr§, Robert L. Vessella and Jin-Tang Dong*

From the Winship Cancer Institute,* Emory University School of Medicine, Atlanta, Georgia; the Departments of Clinical Genetics{dagger} and Pathology,{ddagger} Tampere University Hospital, Tampere, Finland; the Department of Pathology,§ University of Virginia School of Medicine, Charlottesville, Virginia; and the Department of Urology, University of Washington, Seattle, Washington

Kruppel-like factors (KLFs) are a group of transcription factors that appear to be involved in different biological processes including carcinogenesis. In a recent study, KLF6 was reported as a tumor suppressor gene in prostate cancer because of its frequent loss of heterozygosity (LOH) and mutation as well as functional suppression of cell proliferation. Loss of chromosomal locus spanning KLF6 is relatively infrequent in other published studies of prostate cancer, however. To clarify the role of KLF6 in prostate cancers, particularly those that are high grade, we examined KLF6 for deletion, mutation, and loss of expression in 96 prostate cancer samples including 21 xenografts/cell lines. Loss of heterozygosity occurred in 4 (19%) of 21 xenografts/cell lines and 8 (28%) of 29 informative tumors. Fourteen of the 96 (15%) samples showed 15 somatic sequence changes in the KLF6 gene, including 7 that changed KLF6 peptide sequences, 4 that did not, and 4 that were located in untranslated regions. Expression levels of KLF6 were significantly lost in 4 of 20 (20%) xenografts/cell lines of prostate cancer, as detected by RT-PCR and Northern blot analysis. These findings indicate that significant genetic alterations of KLF6 occur in a minority of high-grade prostate cancers.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
I. Bentov, G. Narla, H. Schayek, K. Akita, S. R. Plymate, D. LeRoith, S. L. Friedman, and H. Werner
Insulin-Like Growth Factor-I Regulates Kruppel-Like Factor-6 Gene Expression in a p53-Dependent Manner
Endocrinology, April 1, 2008; 149(4): 1890 - 1897.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
H. Lee, D. Kim, H. C. Dan, E. L. Wu, T. M. Gritsko, C. Cao, S. V. Nicosia, E. A. Golemis, W. Liu, D. Coppola, et al.
Identification and Characterization of Putative Tumor Suppressor NGB, a GTP-Binding Protein That Interacts with the Neurofibromatosis 2 Protein
Mol. Cell. Biol., March 15, 2007; 27(6): 2103 - 2119.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. DiFeo, G. Narla, J. Hirshfeld, O. Camacho-Vanegas, J. Narla, S. L. Rose, T. Kalir, S. Yao, A. Levine, M. J. Birrer, et al.
Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination.
Clin. Cancer Res., June 15, 2006; 12(12): 3730 - 3739.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Matsumoto, A. Kubo, H. Liu, K. Akita, F. Laub, F. Ramirez, G. Keller, and S. L. Friedman
Developmental regulation of yolk sac hematopoiesis by Kruppel-like factor 6
Blood, February 15, 2006; 107(4): 1357 - 1365.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Kirschenbaum, X.-H. Liu, S. Yao, G. Narla, S. L. Friedman, J. A. Martignetti, and A. C. Levine
Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones
Carcinogenesis, February 1, 2006; 27(2): 216 - 224.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Li, S. Yea, G. Dolios, J. A. Martignetti, G. Narla, R. Wang, M. J. Walsh, and S. L. Friedman
Regulation of Kruppel-like Factor 6 Tumor Suppressor Activity by Acetylation
Cancer Res., October 15, 2005; 65(20): 9216 - 9225.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Li, S. Yea, S. Li, Z. Chen, G. Narla, M. Banck, J. Laborda, S. Tan, J. M. Friedman, S. L. Friedman, et al.
Kruppel-like Factor-6 Promotes Preadipocyte Differentiation through Histone Deacetylase 3-dependent Repression of DLK1
J. Biol. Chem., July 22, 2005; 280(29): 26941 - 26952.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Narla, A. DiFeo, S. Yao, A. Banno, E. Hod, H. L. Reeves, R. F. Qiao, O. Camacho-Vanegas, A. Levine, A. Kirschenbaum, et al.
Targeted Inhibition of the KLF6 Splice Variant, KLF6 SV1, Suppresses Prostate Cancer Cell Growth and Spread
Cancer Res., July 1, 2005; 65(13): 5761 - 5768.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
C Hughes, A Murphy, C Martin, O Sheils, and J O'Leary
Molecular pathology of prostate cancer
J. Clin. Pathol., July 1, 2005; 58(7): 673 - 684.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Narla, A. DiFeo, H. L. Reeves, D. J. Schaid, J. Hirshfeld, E. Hod, A. Katz, W. B. Isaacs, S. Hebbring, A. Komiya, et al.
A Germline DNA Polymorphism Enhances Alternative Splicing of the KLF6 Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk
Cancer Res., February 15, 2005; 65(4): 1213 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y.-M. Wu, D. R. Robinson, and H.-J. Kung
Signal Pathways in Up-regulation of Chemokines by Tyrosine Kinase MER/NYK in Prostate Cancer Cells
Cancer Res., October 15, 2004; 64(20): 7311 - 7320.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Rubinstein, G. Idelman, S. R. Plymate, G. Narla, S. L. Friedman, and H. Werner
Transcriptional Activation of the Insulin-Like Growth Factor I Receptor Gene by the Kruppel-Like Factor 6 (KLF6) Tumor Suppressor Protein: Potential Interactions between KLF6 and p53
Endocrinology, August 1, 2004; 145(8): 3769 - 3777.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Ito, M. Uchiyama, M. Kondo, S. Mori, N. Usami, O. Maeda, T. Kawabe, Y. Hasegawa, K. Shimokata, and Y. Sekido
Kruppel-Like Factor 6 Is Frequently Down-Regulated and Induces Apoptosis in Non-Small Cell Lung Cancer Cells
Cancer Res., June 1, 2004; 64(11): 3838 - 3843.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Benzeno, G. Narla, J. Allina, G. Z. Cheng, H. L. Reeves, M. S. Banck, J. A. Odin, J. A. Diehl, D. Germain, and S. L. Friedman
Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1
Cancer Res., June 1, 2004; 64(11): 3885 - 3891.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Narla, S. L. Friedman, and J. A. Martignetti
Kruppel Cripples Prostate Cancer: KLF6 Progress and Prospects
Am. J. Pathol., April 1, 2003; 162(4): 1047 - 1052.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.